NDC 49281-226-65
Fluzone High-Dose Quadrivalent Northern Hemisphere 60 ug/.7mL
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) · INJECTION, SUSPENSION
Fluzone High-Dose Quadrivalent Northern Hemisphere is a injection, suspension containing influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (formaldehyde inactivated), influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) at a strength of 60 ug/.7mL. Manufactured by Sanofi Pasteur Inc..
Key Facts
- Brand Name
- Fluzone High-Dose Quadrivalent Northern Hemisphere
- Generic Name
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)
- NDC Code (Package)
49281-226-65- NDC Code (Product)
49281-226- Manufacturer
- Sanofi Pasteur Inc.
- Strength
- 60 ug/.7mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103914
- Marketing Start
- 07/01/2025
Recall History
No Recall HistoryView Full Drug Page
Fluzone High-Dose Quadrivalent Northern Hemisphere — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.